IMNM Stock Analysis: Buy, Sell, or Hold?
IMNM - Immunome, Inc.
$20.88
-1.14 (-5.18%)
▼
5d:
-6.95%
30d:
-10.23%
90d:
-5.78%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
IMNM is down 3.5% this week, but smart money is accumulating calls. Top strike: $30 2026-07-17 with 341 OI. Call ratio: 88% View Scanner →
Strength: 5.5/10
Get Alerted When IMNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMNM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMNM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMNM is currently trading at $20.88, which is considered oversold relative to its 30-day fair value range of $21.99 to $23.69.
Technical Outlook: Technically, IMNM is showing sideways momentum. The price is currently testing key support at $20.84. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $35.54 (+61.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMNM is showing sideways momentum. The price is currently testing key support at $20.84. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $35.54 (+61.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.99 -
$23.69
Company Quality Score
57/100
(HOLD)
Options IV Signal
42th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
Protect Your Profits
Holding IMNM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 42th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 61.4% below Wall St target ($35.54)
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$21.99 -
$23.69
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$2.38
(11.4%)
Support & Resistance Levels
Support Level
$20.84
Resistance Level
$24.01
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.42
Wall Street Target
$35.54
(+61.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: May 15, 2026 4:39 PM ET
Data refreshes hourly during market hours. Next update: 5:39 PM
Data refreshes hourly during market hours. Next update: 5:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMNM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
5
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Jack Higgins
SELL
9438 shares
2026-04-02
Max Rosett
SELL
65000 shares
2026-04-02
Philip Wagenheim
SELL
28200 shares
2026-03-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 52 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 60 BUY |
Advanced IMNM Option Strategies
Professional options setups generated by AI based on today's IMNM price and gamma walls.
